Before the Marihuana Tax Act of 1937, the main beneficiaries in the timber, cotton, and synthetic-fiber industries in the United States were large companies and corporations that dominated these industries. These companies were mainly based in the northeastern and southern regions of the country.

In the timber industry, companies such as Weyerhaeuser, Georgia-Pacific, and International Paper were among the largest producers of timber products.

In the cotton industry, companies such as J.P. Stevens, American Cotton Manufacturers, and the American Cottonseed Oil Company, were among the leading producers of cotton and cotton-based products.

In the synthetic-fiber industry, companies such as DuPont, Monsanto, and Union Carbide, were among the leading producers of synthetic fibers such as nylon and rayon.

These companies, along with others in these industries, had a significant influence on the economy and politics of the United States at the time and would have been negatively impacted by the growth of hemp as a competitor. They could have seen hemp as a threat to their profits and lobbied for its restriction and prohibition.

It's worth noting that the political and economic situation at the time, combined with the misinformation campaign led by the Federal Bureau of Narcotics, led to the restriction of cannabis, and it's not necessarily the case that these companies were the only or main reason for the restrictions.

Hemp, which is a variety of the Cannabis sativa plant, was banned in the United States along with marijuana in the 1930s. The main reason for the ban was the association of hemp with marijuana, which was being targeted as a drug with dangerous and addictive properties.

Hemp and marijuana are both varieties of the cannabis plant, and they look very similar, which made it difficult to differentiate between the two. They also have similar chemical compounds, including THC (tetrahydrocannabinol), the psychoactive compound that causes the "high" associated with marijuana use.

Another reason for the ban of hemp is that it was considered a major competitor to the timber, cotton, and synthetic-fiber industries. The Marihuana Tax Act of 1937 effectively made it too costly and burdensome for farmers to grow hemp, and it was banned along with marijuana.

In recent years, there has been a renewed interest in hemp as a crop for its uses in products such as paper, textiles, biofuel, and food. In 2018, the U.S. Congress passed the Farm Bill which legalizes hemp production, and the FDA has approved CBD derived from hemp as a dietary supplement. Today, hemp is grown in many states across the country, but it's still heavily regulated and it is illegal to grow hemp in some states.

Marijuana use was first banned in the United States in 1937 with the passage of the Marihuana Tax Act. The Act placed strict regulations on the sale, possession, and use of marijuana, and effectively made marijuana illegal in the US. The Act was passed despite little scientific evidence of marijuana's negative effects, and was largely driven by anti-Mexican sentiment and misinformation about the drug.

The Act was heavily influenced by the Federal Bureau of Narcotics, led by Harry Anslinger, who campaigned against marijuana by spreading misinformation and racist stereotypes about Mexican immigrants and African Americans, who were said to be the main users of marijuana at the time. He claimed that marijuana use led to violence, insanity and moral decay, and that it was a major threat to society.

The Act's passage marked the beginning of marijuana prohibition in the United States, and similar laws were soon passed in other countries. It was not until the 1970's that the laws regarding marijuana began to be reformed, and today several states have legalized marijuana for medical or recreational use.

Cannabidiol (CBD) is being studied for its potential therapeutic benefits, however, it is not currently approved by the U.S. Food and Drug Administration (FDA) as a medicine. The FDA has approved a CBD-based drug called Epidiolex to treat certain forms of epilepsy, but it is not yet widely available.

CBD is considered a dietary supplement and can be found in various forms such as oil, tinctures, capsules, gummies, creams and more. Some people use CBD as a natural remedy for conditions such as anxiety, pain, and insomnia, however, more research is needed to confirm its effectiveness and safety as a medicine.

No, cannabidiol (CBD) is one of many compounds, known as cannabinoids, found in the cannabis plant. It is not the same as tetrahydrocannabinol (THC), which is the compound that causes the "high" associated with marijuana use. CBD is non-psychoactive and is thought to have therapeutic benefits, while THC is psychoactive and primarily responsible for the intoxicating effects of marijuana.

No, as long as you are applying with a marijuana-friendly company. Some companies don't require an exam at all. Other companies don't test for THC. Make sure the agent you work with knows which companies are best for your particular situation. If you don't have an agent, I work with the leading marijuana-friendly companies and will make sure you apply with the best company for you.

The Consumer Product Safety Commission is responsible for the requirements for child safety in packaging in the US.  This relates to all products from household chemicals to pharmaceuticals and is specifically defined in the Poison Prevention Packaging Act (PPPA) of 1970.  The EPA regulates pesticides and other chemicals that require child resistant packaging.  The actual test requirement is specifically defined for child safety (testing children) and senior friendly (testing seniors).  The full test can be found by looking up 16. CFR 1700.20 in the Federal Register.

You will not find marijuana listed in the federal regulation for products requiring child resistant packaging.  The reason is that marijuana is still federally illegal and the CPSC does not have any involvement.  Since the CPSC standard is the only standard used in the US for testing and certifying a package to be child resistant.  Most cannabis state regulators defer to this standard in their specific state regulations.  

Compliance in the beginning was just a "four letter word" and still is in new markets. Early on, we saw the word "compliance" become a buzzword as enforcement took down major players in older markets like Colorado. Everyone, all of a sudden - overnight - became "compliant" or claimed to be. Operators still act like they care about proactive compliance, but few actually manage it well or fully unpack the buzzword.

We've evolved by realizing we can't lead everyone to the waters and expect them to drink and to be selective about which clients we help position as leaders for everyone else to follow. This has allowed us to not waste our time or client's money since you can't work with people who don't truly care about doing the boring and tedious work necessary for long term success and risk mitigation.

These days, we've evolved the conversation beyond the buzzword and reactionary culture to one that values proactive compliance management of processes, people, and macro and micro areas of compliance. We've made it easier to understand and simple for clients to choose their level of protection over the long run. We are a part of their every day struggle to comply and help them achieve compliance objectives and protect themselves.

The future looks like cGAP, cGMP, and ISO standards and international commerce in which we're positioned as global leaders for success.